VA Greater Los Angeles Healthcare System
VA Greater Los Angeles Healthcare System
Explore linked clinical trials.15 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Intracranial Neurophysiological Signatures of Fear and Anxiety in Humans | Stress Disorders, Traumatic, acute stress disorder, generalized anxiety disorder, post-traumatic stress disorder, psychiatric disorder | Recruiting | Not applicable | 2026-08-31 | NCT05120635 | |
| Supported Online Self-Help for Veterans With Depression in Primary Care | depressive disorder | Not yet recruiting | Not applicable | 2026-08-24 | NCT07781228 | |
| A Pragmatic Trial of EAET for Veterans With Chronic Pain | Chronic Pain, Musculoskeletal Pain, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, muscle tissue disorder, musculoskeletal system disorder | Recruiting | Not applicable | 2026-08-24 | NCT07218757 | |
| Evidence-Based Quality Improvement to Reduce VA Primary Care Burnout | Burnout; Burnout Syndrome | Recruiting | Not applicable | 2026-08-19 | NCT07031245 | |
| The FLARE (Flurpiridaz vs. Rubidium Evaluation) Trial | Angina Pectoris, Arterial Occlusive Diseases, Microvascular Angina, arteriosclerosis disorder, cardiovascular disorder, coronary artery disorder, coronary microvascular disorder, heart disorder, myocardial ischemia, vascular disorder | Enrolling by invitation | Not stated | 2026-08-17 | NCT07761728 | |
| Multi-center Trial to Improve Nocturia and Sleep in Older Adults | Dyssomnias, Lower Urinary Tract Symptoms, Nocturia, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Sleep Disorders, Intrinsic, Urological Manifestations, insomnia, nervous system disorder, psychiatric disorder, sleep-wake disorder | Recruiting | Not applicable | 2026-08-13 | NCT06110091 | |
| A Dyadic Sleep Health Approach for Persons With Alzheimer's Disease and Caregivers | brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, psychiatric disorder | Recruiting | Not applicable | 2026-06-18 | NCT05452031 | |
| Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer. | Genital Diseases, Male Urogenital Diseases, Neoplasm Metastasis, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, metastatic malignant neoplasm, neoplasm, prostate cancer, prostate disorder | Recruiting | Phase 2 | 2026-06-15 | NCT05422911 | |
| COVID-19 Outcome Prediction Algorithm | COVID-19, Chronic Disease, Coronaviridae Infections, Disease Attributes, Frailty, Frailty Syndrome, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Post-Infectious Disorders, RNA Virus Infections, Shock, long COVID-19, lung disorder, multiple organ dysfunction syndrome, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Active, not recruiting | Not stated | 2026-04-24 | NCT05471011 | |
| EZH2 Inhibitor, Tulmimetostat, and PD-1 Blockade for Treatment of Advanced Non-small Cell Lung Cancer | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 1 / Phase 2 | 2026-01-27 | NCT05467748 | |
| Assessing an EEG Biomarker of Response to TMS for Major Depression | depressive disorder | Active, not recruiting | Not stated | 2025-10-22 | NCT05008198 | |
| K08 VR Fear Conditioning | Stress Disorders, Traumatic, acute stress disorder, anxiety disorder, post-traumatic stress disorder, psychiatric disorder | Enrolling by invitation | Not applicable | 2025-10-14 | NCT07216222 | |
| Serial PET MPI in Patients Undergoing Cancer Treatment | Angina Pectoris, Arterial Occlusive Diseases, Microvascular Angina, arteriosclerosis disorder, cancer, cardiovascular disorder, coronary artery disorder, coronary microvascular disorder, heart disorder, myocardial ischemia, neoplasm, vascular disorder | Enrolling by invitation | Not stated | 2025-08-06 | NCT05913999 | |
| Integrating Metabolic and Vascular Sensors to Monitor Cardiometabolic Disorders After Nutrition Interventions | Digestive System Diseases, fatty liver disease, liver disorder, metabolic dysfunction-associated steatotic liver disease | Not yet recruiting | Not applicable | 2025-04-17 | NCT06932289 | |
| 18F-Fluciclovine PET/CT Impact on Predicting Clinical Outcome of 177Lu-PSMA-617 Therapy in Patients With Prostate Cancer | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Prostatic Neoplasms, Castration-Resistant, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, metastatic prostate carcinoma, neoplasm, prostate cancer, prostate disorder | Recruiting | Phase 4 | 2024-11-27 | NCT06706921 |